Recent Comments

Comment RSS

Hepatitis C News and Research RSS Feed - Hepatitis C News and Research

Hepatitis C is one type of hepatitis - a liver disease - caused by the hepatitis C virus (HCV). It usually spreads through contact with infected blood. It can also spread through sex with an infected person and from mother to baby during childbirth.

Most people who are infected with hepatitis C don't have any symptoms for years. A blood test can tell if you have it. Usually, hepatitis C does not get better by itself. The infection can last a lifetime and may lead to scarring of the liver or liver cancer. Medicines sometimes help, but side effects can be a problem. Serious cases may need a liver transplant.

First nationwide human immunology registry for infectious disease research

21. November 2009 00:00
RemedyMD (www.RemedyMD.com), the leading provider of disease registry software, today announced the first nationwide human immunology registry for infectious disease research. The new registry was developed to help clinicians and researchers better understand the human immune response to emerging and re-emerging infectious diseases. [More]

Posted in: Device / Technology News | Disease/Infection News | Healthcare News

Tags: , , , ,

Hepatitis C Virus therapeutics development landscape continues to inflate

20. November 2009 01:06
Research and Markets (http://www.researchandmarkets.com/research/f6bf5e/hepatitis_c_virus) has announced the addition of the "Hepatitis C Virus And Therapeutics - A Global Update of Market Trends & Opportunities" report to their offering. [More]

Posted in: Disease/Infection News | Pharmaceutical News

Tags: , , ,

Epiphany Biosciences announces results from its valomaciclovir Phase 2b trial for shingles

18. November 2009 08:52
Epiphany Biosciences announced results from its Phase 2b dose-ranging study of EPB-348 (valomaciclovir) in patients with shingles (herpes zoster) infection. The study's primary endpoint was non-inferiority of once-daily valomaciclovir compared to thrice-daily valacyclovir in terms of time to complete crusting of the shingles rash. [More]

IBM scientists create one-step point-of-care-diagnostic test based on innovative silicon chip

18. November 2009 05:12
IBM (IBM) scientists have created a one-step point-of-care-diagnostic test, based on an innovative silicon chip, that requires less sample volume, is significantly faster, portable, easy to use, and can test for many diseases, including one of world's leading causes of death, cardiovascular disease. [More]

On-going Phase 2b study conducted by Roche of ITMN-191 modified

18. November 2009 03:55
InterMune, Inc. today announced that the on-going Phase 2b study conducted by Roche of ITMN-191 (RG7227) combined with standard of care (SOC) PEGASYS® (peginterferon alfa-2a) and COPEGUS® (ribavirin) in HCV treatment-naive patients has been modified. [More]

FDA issues a Complete Response Letter for Human Genome Sciences' raxibacumab BLA

16. November 2009 07:53
Human Genome Sciences, Inc. today announced that it has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) relating to the Company’s Biologics License Application (BLA) requesting the approval of raxibacumab for use in the treatment of inhalational anthrax. The FDA issues Complete Response Letters to request additional information needed to complete the review of a BLA. [More]

Inovio Biomedical reports financial results for the three and nine months ended September 30, 2009

16. November 2009 06:42
Inovio Biomedical Corporation today reported financial results for the three and nine months ended September 30, 2009. [More]

Chembio Diagnostics to donate more than 4,500 rapid HIV test kits

16. November 2009 02:25
Chembio Diagnostics, Inc., a NY-based company that develops, manufactures, licenses and markets proprietary rapid diagnostic tests, is donating more than 4,500 rapid HIV test kits to the AIDS Healthcare Foundation's 2009 Testing Millions Global Campaign, based in Los Angeles, to commemorate World AIDS Day 2009 on December 1st. [More]

Posted in: Device / Technology News | Disease/Infection News

Tags: , , ,

UT Southwestern Medical Center awarded $42M for basic and patient-oriented research

13. November 2009 00:08
UT Southwestern Medical Center has been awarded more than $42 million to date for basic and patient-oriented research from the American Recovery and Reinvestment Act of 2009, the $787 billion stimulus package President Barack Obama signed into law in February. [More]

Tips for preventing cancer

12. November 2009 23:50
The risk of cancer can be dramatically reduced through everyday choices about diet, exercise and tobacco use, according to a Special Report on Cancer Prevention in the November issue of Mayo Clinic Women's HealthSource. [More]

AVMA confirms that a household cat in Iowa showed signs of H1N1 influenza

12. November 2009 03:51
Amarillo Biosciences, Inc. reported that the American Veterinary Medical Association (AVMA) recently confirmed that a household cat in Iowa developed signs of respiratory infection caused by H1N1 influenza virus. [More]

Posted in: Disease/Infection News

Tags: , , , , , , ,

Future trends in the injectable drug delivery market

11. November 2009 03:21
As competition in the pharmaceutical marketplace grows, companies are increasingly looking towards the drug delivery industry to maximize revenues and combat generic competitors. The search for more efficient drug delivery systems is also being driven by the rise in patient demand, healthcare and pharma cost containment, as much as by medical and technological advances. [More]

Aduro BioTech raises funds through its Series A-1 financing

10. November 2009 23:27
Aduro BioTech, a privately held biotechnology company focused on the development of therapeutic and prophylactic vaccines based on proprietary recombinant strains of the bacterium Listeria monocytogenes, today announced completion of its Series A-1 financing. [More]

Posted in: Business / Finance

Tags: , , , , , , , , ,

NIH awards $6.8 million subcontract to Kineta to develop vaccine immune boosters

10. November 2009 05:35
Kineta, Inc. announced today it has been awarded a $6.8 million subcontract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop novel vaccine adjuvants (agents that help boost the immune system). The Kineta subcontract is part of a larger $13 million award to the University of Washington. [More]

Study: Patients with difficult to treat hepatitis C are half as likely to initiate treatment

10. November 2009 04:36
A new study by Mount Sinai researchers has for the first time found that patients with more difficult to treat forms of hepatitis C are half as likely to initiate treatment for the disease, when compared to patients with hepatitis C that is easier to treat. Marital status also affected whether patients chose treatment, as did whether or not they had other diseases. [More]

Posted in: Disease/Infection News

Tags: , , ,

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.